Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 14
Selected: 0
NCT IDTitle
NCT01961830Intrapulmonary Pharmacokinetics of ME1100 in Healthy Volunteers
NCT05905055P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales
NCT02134834A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595
NCT05887908Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis
NCT02022215Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
NCT01907776Pharmacokinetics and Safety Study of ME1100 in Healthy Volunteers
NCT04785326Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis
NCT01841996Pharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients
NCT02100917Bioequivalence Study Evaluating the Pharmacokinetics of DMB-3111 and Trastuzumab in Healthy Japanese Male Adults
NCT01933919A Phase 3 Study of Fluvoxamine (SME3110) in Pediatric/Adolescent Patients With Obsessive Compulsive Disorder
NCT01142596Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125)
NCT01659515Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant Bacteria
NCT02459158A Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia
NCT02927353A Phase 1 Pharmacokinetic Bioequivalence Study of DMB-3113 and Adalimumab in Healthy Japanese Adult Male Subjects